Cumberland Pharmaceuticals CPIX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $11.01M-27.1% | $11.44M-36.3% | $15.2M-13.0% | $16.09M-7.2% | $15.11M-18.5% | ||
| $14.26M+36.0% | $16.94M+44.8% | $10.43M-7.8% | $10.32M-11.2% | $10.49M-1.5% | ||
| $9.88M-0.6% | $9.25M-15.9% | $9.18M-22.4% | $9.53M-19.7% | $9.94M-23.0% | ||
| $32.79M+2.9% | $37.06M+1.7% | $29.94M-15.0% | $31.21M-12.3% | $31.88M-12.0% | ||
| $237.38K-20.5% | $264.72K-4.6% | $293.38K-6.0% | $297.79K-11.7% | $298.74K-19.1% | ||
| $914K0.0% | $914K0.0% | $914K0.0% | $914K0.0% | $914K0.0% | ||
| $12.79M-24.7% | $14.03M-22.0% | $15.01M-22.7% | $15.99M-21.9% | $16.99M-21.1% | ||
| —— | —— | —— | —— | —— | ||
| $71M+1.5% | $76.82M+1.6% | $65.9M-14.1% | $67.91M-13.5% | $69.94M-14.2% | ||
| $16.54M+18.7% | $18.57M+33.4% | $13.83M+14.7% | $13.45M+7.5% | $13.93M+6.5% | ||
| —— | —— | —— | —— | —— | ||
| $34.49M+35.1% | $36.74M+16.2% | $24.31M-21.8% | $23.97M-3.2% | $25.52M-3.4% | ||
| $49.69M+19.5% | $52.28M-1.4% | $40.1M-23.3% | $40.23M-23.4% | $41.6M-23.4% | ||
| $51.73M+0.7% | $51.68M+10.4% | $51.51M+10.0% | $51.44M+9.8% | $51.37M+9.5% | ||
| -$30.09M-32.5% | -$26.8M-11.8% | -$25.39M-15.1% | -$23.45M-14.3% | -$22.71M-16.9% | ||
| $21.64M-24.5% | $24.88M+8.9% | $26.12M+5.4% | $27.99M+6.2% | $28.66M+4.2% | ||
| $71M+1.5% | $76.82M+1.6% | $65.9M-14.1% | $67.91M-13.5% | $69.94M-14.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Cumberland Pharmaceuticals's total assets?
- Cumberland Pharmaceuticals (CPIX) holds $71.0M in total assets, up 1.5% year over year.
- How much debt does Cumberland Pharmaceuticals have?
- Cumberland Pharmaceuticals carries $4.8M in total debt against $21.6M of shareholders' equity, a debt-to-equity ratio of 0.22.
- How much cash does Cumberland Pharmaceuticals have?
- Cumberland Pharmaceuticals holds $11.0M in cash and equivalents.
- Can Cumberland Pharmaceuticals cover its short-term obligations?
- Its current ratio is 0.95 — current liabilities exceed current assets.
- Where does Cumberland Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Cumberland Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
